Loading...
Myelosuppression After Frontline Fludarabine, Cyclophosphamide, and Rituximab in Patients With Chronic Lymphocytic Leukemia: Analysis of Persistent and New-Onset Cytopenia
BACKGROUND: The combination of fludarabine, cyclophosphamide, and rituximab (FCR) has produced improved response rates and a prolonged survival in patients with chronic lymphocytic leukemia (CLL). However, its therapeutic power is counterbalanced by significant hematologic toxicity. Persistent and n...
Saved in:
| Published in: | Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4535913/ https://ncbi.nlm.nih.gov/pubmed/23943357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28318 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|